Neurocrine, Soleno HSR waiting period expired April 27
MLex Summary: Neurocrine Biosciences and Soleno Therapeutics received US regulatory clearance for their proposed merger on April 27 when the Hart-Scott-Rodino waiting period expired just before midnight.Excerpt: ...To view the full article, register now.
Already a subscriber? Click here to view full article